Surgalign Holdings Revenue | SRGA

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.^[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue Surgalign Holdings

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
82 M	90.5 M	102 M	117 M	92.1 M	90.3 M	276 M	282 M	263 M	198 M	178 M	169 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
282 M	82 M	162 M

Quarterly Revenue Surgalign Holdings

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
16.7 M	-	20.2 M	20.6 M	20.6 M	-	20.5 M	24.8 M	23.3 M	26.2 M	27.9 M	54.2 M	73.7 M	31.6 M	76.1 M	82.3 M	69.7 M	23.1 M	24.1 M	22.4 M	22.5 M	71.1 M	67.2 M	71.6 M	70.4 M	-	66.5 M	69.9 M	67.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
82.3 M	16.7 M	44.8 M

References

Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Medical devices industry

Issuer	Revenue	Price	% 24h	Market Cap	Country
AxoGen AXGN	225 M	$ 43.32	0.04 %	$ 1.99 B	USA
Bruker Corporation BRKR	3.44 B	$ 59.67	0.18 %	$ 9.06 B	USA
Cognyte Software Ltd. CGNT	400 M	$ 8.73	1.16 %	$ 637 M	Israel
ClearPoint Neuro CLPT	37 M	$ 14.97	13.03 %	$ 424 M	USA
Conformis CFMS	62 M	-	-	$ 16.4 M	USA
CONMED Corporation CNMD	1.37 B	$ 45.8	3.31 %	$ 1.42 B	USA
Cytosorbents Corporation CTSO	37.1 M	$ 4.91	0.75 %	$ 306 M	USA
Delcath Systems DCTH	85.2 M	$ 15.96	1.8 %	$ 572 M	USA
Eargo EAR	37.2 M	-	-	$ 10.2 M	USA
AdaptHealth Corp. AHCO	3.24 B	$ 5.7	0.43 %	$ 770 M	USA
Electromed ELMD	73.8 M	$ 27.57	0.11 %	$ 228 M	USA
Establishment Labs Holdings ESTA	211 M	$ 67.76	3.69 %	$ 2.01 B	Costa-rica
Edwards Lifesciences Corporation EW	6.07 B	$ 86.82	0.51 %	$ 50.8 B	USA
Align Technology ALGN	4.03 B	$ 148.17	4.36 %	$ 10.7 B	USA
Helius Medical Technologies HSDT	6.02 M	$ 2.88	2.45 %	$ 63.5 M	USA
Integra LifeSciences Holdings Corporation IART	1.64 B	$ 15.53	2.76 %	$ 1.19 B	USA
Inogen INGN	349 M	$ 5.09	2.55 %	$ 135 M	USA
Inspire Medical Systems INSP	912 M	$ 69.06	0.57 %	$ 2.03 B	USA
IRIDEX Corporation IRIX	52.7 M	$ 0.63	0.08 %	$ 10.7 M	USA
IRadimed Corporation IRMD	83.8 M	$ 86.35	0.08 %	$ 1.1 B	USA
Integer Holdings Corporation ITGR	1.85 B	$ 126.32	0.02 %	$ 4.39 B	USA
LENSAR LNSR	58.4 M	$ 7.15	0.14 %	$ 85.5 M	USA
Medigus Ltd. MDGS	29.9 M	-	10.28 %	$ 55.5 M	Israel
Apyx Medical Corporation APYX	52.8 M	$ 2.95	1.37 %	$ 121 M	USA
Cutera CUTR	49.5 M	-	-10.19 %	$ 1.99 M	USA
Medtronic PLC MDT	36.4 B	$ 89.3	0.08 %	$ 114 B	USA
MiMedx Group MDXG	419 M	$ 4.77	0.2 %	$ 705 M	USA
Accuray Incorporated ARAY	402 M	$ 0.23	1.0 %	$ 28.2 M	USA
Myomo MYO	40.9 M	$ 1.64	0.3 %	$ 68.6 M	USA
Nano-X Imaging Ltd. NNOX	13 M	$ 0.7	0.45 %	$ 45.4 M	Israel
Nemaura Medical NMRD	77 K	-	-17.8 %	$ 2.74 M	Britain
InspireMD NSPR	8.98 M	$ 0.74	0.16 %	$ 47.6 M	Israel
Orthofix Medical OFIX	822 M	$ 9.18	2.23 %	$ 364 M	Curacao
Outset Medical OM	119 M	$ 3.09	5.45 %	$ 47 K	USA
Boston Scientific Corporation BSX	20.1 B	$ 44.62	0.31 %	$ 66.1 B	USA
Insulet Corporation PODD	2.71 B	$ 136.49	0.01 %	$ 9.6 B	USA
Profound Medical Corp. PROF	16.1 M	$ 5.74	0.16 %	$ 174 M	Canada
Quanterix Corporation QTRX	139 M	$ 3.16	4.93 %	$ 135 M	USA
AVITA Medical RCEL	71.6 M	$ 10.95	0.61 %	$ 305 M	Australia
Neovasc NVCN	2.55 M	-	-	$ 111 M	Canada
Sintx Technologies SINT	1.02 M	$ 1.78	3.98 %	$ 4.94 M	USA
Smith & Nephew plc SNN	4.56 B	$ 26.82	0.07 %	$ 23.3 B	Britain
Inari Medical NARI	494 M	-	-	$ 4.23 B	USA
Sensus Healthcare SRTS	27.5 M	$ 3.03	0.32 %	$ 49.5 M	USA
Stryker Corporation SYK	7.17 B	$ 273.4	0.38 %	$ 104 B	USA
Tactile Systems Technology TCMD	330 M	$ 22.43	0.55 %	$ 513 M	USA
TELA Bio TELA	80.3 M	$ 1.3	0.71 %	$ 61 M	USA
Viemed Healthcare VMD	270 M	$ 8.8	1.24 %	$ 342 M	USA
Varex Imaging Corporation VREX	845 M	$ 18.45	0.05 %	$ 764 M	USA
Sientra SIEN	25.1 M	-	-16.59 %	$ 10.3 M	USA